Claritev Shares Gain After 4Q Revenue Meets Previous Guidance

Dow Jones

Feb 27, 2025

By Josh Beckerman

Shares of Claritev rose after it reported revenue in the fourth quarter on par with its previously issued guidance.

The stock increased 18%, to $23.13, midday Wednesday and is up about 57% this year.

Claritev said it had fourth-quarter revenue of $232.1 million, down 4.9% from a year earlier but slightly up from the third-quarter figure of $230.5 million. The company guided in November for fourth-quarter results similar to the third quarter.

The company, which changed its name from MultiPlan, said it would trade under a new ticker symbol, CTEV, on Friday. The company's operations include analytics-based services that detect medical claims over-charges and recommend reimbursement amounts for out-of-network costs, and operation of preferred provider networks.

Net loss was $138 million, compared with a loss of $31.4 million a year earlier, partly due to an impairment charge stemming from the name change.

Claritev expects 2025 revenue between a 2% decline and flat compared with 2024.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

February 26, 2025 14:05 ET (19:05 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2514618358"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514618358\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2514618358?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 03:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514618358","market":"sh","top_or_hot":-1,"title":"Claritev Shares Gain After 4Q Revenue Meets Previous Guidance","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Josh Beckerman \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Claritev rose after it reported revenue in the fourth quarter on par with its previously issued guidance. \n</p>\n<p>\n  The stock increased 18%, to $23.13, midday Wednesday and is up about 57% this year. \n</p>\n<p>\n  Claritev said it had fourth-quarter revenue of $232.1 million, down 4.9% from a year earlier but slightly up from the third-quarter figure of $230.5 million. The company guided in November for fourth-quarter results similar to the third quarter. \n</p>\n<p>\n  The company, which changed its name from MultiPlan, said it would trade under a new ticker symbol, CTEV, on Friday. The company's operations include analytics-based services that detect medical claims over-charges and recommend reimbursement amounts for out-of-network costs, and operation of preferred provider networks. \n</p>\n<p>\n  Net loss was $138 million, compared with a loss of $31.4 million a year earlier, partly due to an impairment charge stemming from the name change. \n</p>\n<p>\n  Claritev expects 2025 revenue between a 2% decline and flat compared with 2024. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 26, 2025 14:05 ET (19:05 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Claritev Shares Gain After 4Q Revenue Meets Previous Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClaritev Shares Gain After 4Q Revenue Meets Previous Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-27 03:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Josh Beckerman \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Claritev rose after it reported revenue in the fourth quarter on par with its previously issued guidance. \n</p>\n<p>\n  The stock increased 18%, to $23.13, midday Wednesday and is up about 57% this year. \n</p>\n<p>\n  Claritev said it had fourth-quarter revenue of $232.1 million, down 4.9% from a year earlier but slightly up from the third-quarter figure of $230.5 million. The company guided in November for fourth-quarter results similar to the third quarter. \n</p>\n<p>\n  The company, which changed its name from MultiPlan, said it would trade under a new ticker symbol, CTEV, on Friday. The company's operations include analytics-based services that detect medical claims over-charges and recommend reimbursement amounts for out-of-network costs, and operation of preferred provider networks. \n</p>\n<p>\n  Net loss was $138 million, compared with a loss of $31.4 million a year earlier, partly due to an impairment charge stemming from the name change. \n</p>\n<p>\n  Claritev expects 2025 revenue between a 2% decline and flat compared with 2024. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 26, 2025 14:05 ET (19:05 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CTEV","symbol_name":"Claritev Corporation","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2514618358","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514618358","pubTimestamp":1740596700,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Claritev rose after it reported revenue in the fourth quarter on par with its previously issued guidance.The stock increased 18%, to $23.13, midday Wednesday and is up about 57% this year.Claritev said it had fourth-quarter revenue of $232.1 million, down 4.9% from a year earlier but slightly up from the third-quarter figure of $230.5 million. The company guided in November for fourth-quarter results similar to the third quarter.The company, which changed its name from MultiPlan, said it would trade under a new ticker symbol, CTEV, on Friday. The company's operations include analytics-based services that detect medical claims over-charges and recommend reimbursement amounts for out-of-network costs, and operation of preferred provider networks.Net loss was $138 million, compared with a loss of $31.4 million a year earlier, partly due to an impairment charge stemming from the name change.Claritev expects 2025 revenue between a 2% decline and flat compared with 2024.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CTEV":"Claritev Corporation"},"translate_title":"第四季度收入达到之前的指引后，Claritev股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MPLN":0.9,"CTEV":0.9},"content_text":"By Josh Beckerman \n\n\n \n\n\n  Shares of Claritev rose after it reported revenue in the fourth quarter on par with its previously issued guidance. \n\n\n  The stock increased 18%, to $23.13, midday Wednesday and is up about 57% this year. \n\n\n  Claritev said it had fourth-quarter revenue of $232.1 million, down 4.9% from a year earlier but slightly up from the third-quarter figure of $230.5 million. The company guided in November for fourth-quarter results similar to the third quarter. \n\n\n  The company, which changed its name from MultiPlan, said it would trade under a new ticker symbol, CTEV, on Friday. The company's operations include analytics-based services that detect medical claims over-charges and recommend reimbursement amounts for out-of-network costs, and operation of preferred provider networks. \n\n\n  Net loss was $138 million, compared with a loss of $31.4 million a year earlier, partly due to an impairment charge stemming from the name change. \n\n\n  Claritev expects 2025 revenue between a 2% decline and flat compared with 2024. \n\n\n \n\n\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2025 14:05 ET (19:05 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}